The 2023 Canadian Cardiovascular Society/Canadian Association of Interventional Cardiology guidelines for the use of antiplatelet therapy were presented on October 28th at Vascular 2023 in Montreal and simultaneously published in the Canadian Journal of Cardiology. CVC faculty member, Dr. Kevin Bainey, was a key contributor to these guidelines as both the Guidelines Panel co-chair and lead author.
The new guidelines help clinicians navigate the use of contemporary antiplatelet therapy, a group of medicines that prevent the formation of blood clots after a heart attack, and/or following a stent procedure, or open-heart bypass surgery. In an interview with U of A’s Folio, Dr. Bainey says “It’s important for us to provide clinicians with the most up-to-date contemporary evidence to improve patient care and patient outcomes. Many of these therapies lead toward improvements in survival for our cardiovascular patients.”
Read the full article in folio here.
